{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T22:06:11Z","timestamp":1791237971026,"version":"4.1.0"},"reference-count":13,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":128,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["JP18K08265"],"award-info":[{"award-number":["JP18K08265"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"KAKENHI","doi-asserted-by":"publisher","award":["JP21K08296"],"award-info":[{"award-number":["JP21K08296"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Filaggrin-2 (FLG2) and hornerin (HRNR) are members of the S100 fused-type protein family, which share many properties with filaggrin (FLG). A previous study demonstrated that the expression of FLG2 was significantly decreased in psoriatic skin relative to that in normal skin. In contrast, the HRNR expression in psoriatic skin varied among studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to investigate the effect of tumour necrosis factor-\u03b1 (TNF-\u03b1), IL-17A and IL-22 on the expression of FLG2 and HRNR using a three-dimensional psoriatic skin model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In the present study, we generated a 3D psoriatic skin model that was stimulated with TNF-\u03b1, IL-17A and IL-22 for 3D skin equivalents. Using this model, we examined the altered expression of FLG2 and HRNR by quantitative reverse transcription polymerase chain reaction and immunostaining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the 3D psoriatic skin model, the expression of FLG2 and HRNR was significantly reduced compared with that in the 3D control skin. FLG2 expression was significantly decreased by stimulation with TNF-\u03b1, IL-17A and IL-22. In contrast, the expression of HRNR was markedly increased by stimulation with IL-22, although it was slightly decreased by TNF-\u03b1 or IL-17A compared to the 3D control skin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>TNF-\u03b1, IL-17A and IL-22 have different effects on FLG2 and HRNR expression and epidermal structure formation. Furthermore, FLG2 and HRNR may play different roles in barrier formation and the pathogenesis of psoriasis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ski2.440","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T01:29:10Z","timestamp":1725586150000},"source":"Crossref","is-referenced-by-count":5,"title":["Effect of Tumour Necrotic Factor-\u03b1, Interleukin-17 and Interleukin-22 on the Expression of Filaggerin-2 and Hornerin: Analysis of a Three-Dimensional Psoriatic Skin Model"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0536-1679","authenticated-orcid":false,"given":"Teruhiko","family":"Makino","sequence":"first","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3348-3240","authenticated-orcid":false,"given":"Megumi","family":"Mizawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keita","family":"Takemoto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadamichi","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Faculty of Medicine, Academic Assembly, University of Toyama , Toyama ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"issue":"10275","key":"2025112606020708300_ski2440-bib-0001","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/s0140-6736(21)00184-7","article-title":"Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis","volume":"397","author":"Ghoreschi","year":"2021","journal-title":"Lancet"},{"key":"2025112606020708300_ski2440-bib-0002","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","article-title":"The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the \u2018fused genes\u2019 family","volume":"21","author":"Kypriotou","year":"2012","journal-title":"Exp Dermatol"},{"issue":"1","key":"2025112606020708300_ski2440-bib-0003","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbrc.2014.04.165","article-title":"Expression of filaggrin-2 protein in the epidermis of human skin diseases: a comparative analysis with filaggrin","volume":"449","author":"Makino","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2025112606020708300_ski2440-bib-0004","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1074\/jbc.m409026200","article-title":"Identification of human hornerin and its expression in regenerating and psoriatic skin","volume":"280","author":"Takaishi","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"2025112606020708300_ski2440-bib-0005","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1346-8138.1991.tb03057.x","article-title":"Abnormal distribution of epidermal protein antigens in psoriatic epidermis","volume":"18","author":"Watanabe","year":"1991","journal-title":"J Dermatol"},{"issue":"6","key":"2025112606020708300_ski2440-bib-0006","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/jid.2011.24","article-title":"TNF-alpha downregulates filaggrin and loricrin through c-Jun N-terminal kinase: role for TNF-alpha antagonists to improve skin barrier","volume":"131","author":"Kim","year":"2011","journal-title":"J Invest Dermatol"},{"issue":"12","key":"2025112606020708300_ski2440-bib-0007","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1111\/exd.14797","article-title":"Altered expression of S100 fused-type proteins in an atopic dermatitis skin model","volume":"32","author":"Makino","year":"2023","journal-title":"Exp Dermatol"},{"issue":"2","key":"2025112606020708300_ski2440-bib-0008","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/jdv.15301","article-title":"JAK1\/3 inhibition preserves epidermal morphology in full-thickness 3D skin models of atopic dermatitis and psoriasis","volume":"33","author":"Clarysse","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"2025112606020708300_ski2440-bib-0009","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/bjd.20827","article-title":"Bimekizumab for the treatment of moderate-to-severe plaque psoriasis: efficacy, safety, pharmacokinetics, pharmacodynamics and transcriptomics from a phase IIa, randomized, double-blind multicentre study","volume":"186","author":"Oliver","year":"2022","journal-title":"Br J Dermatol"},{"issue":"6","key":"2025112606020708300_ski2440-bib-0010","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/jid.2008.370","article-title":"Highly complex peptide aggregates of the S100 fused-type protein hornerin are present in human skin","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"issue":"7","key":"2025112606020708300_ski2440-bib-0011","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040797","article-title":"The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1\/2","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"2025112606020708300_ski2440-bib-0012","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/bf00371784","article-title":"Normal psoriatic epidermis expression of hyperproliferation-associated keratins","volume":"283","author":"Thewes","year":"1991","journal-title":"Arch Dermatol Res"},{"issue":"5","key":"2025112606020708300_ski2440-bib-0013","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1046\/j.1523-1747.2001.01327.x","article-title":"Keratins and the keratinocyte activation cycle","volume":"116","author":"Freedberg","year":"2001","journal-title":"J Invest Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/6\/ski2.440\/61412250\/skinhd_4_6_e440.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/6\/ski2.440\/61412250\/skinhd_4_6_e440.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T11:02:15Z","timestamp":1764154935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.440\/7950875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":13,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,9,5]]},"published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.440","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,9,5]]},"article-number":"ski2.440"}}